BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 3007986)

  • 1. Secretion of chromogranin A by peptide-producing endocrine neoplasms.
    O'Connor DT; Deftos LJ
    N Engl J Med; 1986 May; 314(18):1145-51. PubMed ID: 3007986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrinomas and neuroendocrine carcinomas: APUD cell system neoplasms and their aberrant secretory activities.
    Gould VE
    Pathol Annu; 1977; 12 Pt 2():33-62. PubMed ID: 202912
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues.
    O'Connor DT; Burton D; Deftos LJ
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1084-6. PubMed ID: 6352725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma.
    Hsiao RJ; Parmer RJ; Takiyyuddin MA; O'Connor DT
    Medicine (Baltimore); 1991 Jan; 70(1):33-45. PubMed ID: 1988765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone-negative, chromogranin A-positive endocrine tumors.
    Sobol RE; Memoli V; Deftos LJ
    N Engl J Med; 1989 Feb; 320(7):444-7. PubMed ID: 2536475
    [No Abstract]   [Full Text] [Related]  

  • 6. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.
    Tsuchihashi T; Yamaguchi K; Abe K; Yanaihara N; Saito S
    Jpn J Clin Oncol; 1992 Aug; 22(4):232-7. PubMed ID: 1359172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine sources of chromogranin-A in normal man: clues from selective stimulation of endocrine glands.
    Takiyyuddin MA; Cervenka JH; Pandian MR; Stuenkel CA; Neumann HP; O'Connor DT
    J Clin Endocrinol Metab; 1990 Aug; 71(2):360-9. PubMed ID: 2116438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma.
    O'Connor DT; Bernstein KN
    N Engl J Med; 1984 Sep; 311(12):764-70. PubMed ID: 6472366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The ectopic ACTH syndrome].
    Pelkonen R; Nousiainen R; Kontinen E; Sivula A
    Duodecim; 1978; 94(22):1377-84. PubMed ID: 214286
    [No Abstract]   [Full Text] [Related]  

  • 10. Production of GAWK (chromogranin-B 420-493)-like immunoreactivity by endocrine tumors and its possible diagnostic value.
    Sekiya K; Ghatei MA; Salahuddin MJ; Bishop AE; Hamid QA; Ibayashi H; Polak JM; Bloom SR
    J Clin Invest; 1989 Jun; 83(6):1834-42. PubMed ID: 2723061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma chromogranin A in prostatic carcinoma and neuroendocrine tumors.
    Kimura N; Hoshi S; Takahashi M; Takeha S; Shizawa S; Nagura H
    J Urol; 1997 Feb; 157(2):565-8. PubMed ID: 8996358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
    Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromogranins--new sensitive markers for neuroendocrine tumors.
    Eriksson B; Arnberg H; Oberg K; Hellman U; Lundqvist G; Wernstedt C; Wilander E
    Acta Oncol; 1989; 28(3):325-9. PubMed ID: 2545231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphologic and functional aspects of hormone-producing tumors.
    Kameya T; Shimosato Y; Abe K; Takeuchi T
    Pathol Annu; 1980; 15(Pt 1):351-86. PubMed ID: 6255400
    [No Abstract]   [Full Text] [Related]  

  • 15. Chromogranin A and B messenger ribonucleic acids in pituitary and other normal and neoplastic human endocrine tissues.
    Lloyd RV; Iacangelo A; Eiden LE; Cano M; Jin L; Grimes M
    Lab Invest; 1989 Apr; 60(4):548-56. PubMed ID: 2709813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours.
    Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G
    J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma chromogranin-A in primary hyperparathyroidism.
    Nanes MS; O'Connor DT; Marx SJ
    J Clin Endocrinol Metab; 1989 Nov; 69(5):950-5. PubMed ID: 2571619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.
    Fassbender WJ; Krohn-Grimberghe B; Görtz B; Litzlbauer D; Stracke H; Raue F; Kaiser HE
    Anticancer Res; 2000; 20(6C):4877-87. PubMed ID: 11205236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromogranin A and the alpha-subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma.
    Guignat L; Bidart JM; Nocera M; Comoy E; Schlumberger M; Baudin E
    Br J Cancer; 2001 Mar; 84(6):808-12. PubMed ID: 11259096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
    Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
    Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.